B-cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement

Am J Hematol. 2020 Nov;95(11):1427-1429. doi: 10.1002/ajh.25801. Epub 2020 Apr 15.

Authors

Paul G Kemps^{1

2}, Arjen H G Cleven³, Tom van Wezel³, Ronald van Eijk³, Freek J Bot⁴, Hendrik Veelken⁵, Peter van Balen⁵, Jean-Louis H Kerkhoffs¹

Affiliations

¹ Department of Hematology, HagaZiekenhuis, The Hague, The Netherlands.
² Leiden University Medical Center, Leiden, The Netherlands.
³ Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
⁴ Department of Pathology, HagaZiekenhuis, The Hague, The Netherlands.
⁵ Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Gene Rearrangement*
Histone-Lysine N-Methyltransferase / genetics*
Humans
Male
Myeloid-Lymphoid Leukemia Protein / genetics*
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / metabolism
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / pathology
Skin Neoplasms* / drug therapy
Skin Neoplasms* / genetics
Skin Neoplasms* / metabolism
Skin Neoplasms* / pathology

Substances

KMT2A protein, human
Myeloid-Lymphoid Leukemia Protein
Histone-Lysine N-Methyltransferase